Cassava Sciences (SAVA)
(Delayed Data from NSDQ)
$10.08 USD
-0.10 (-0.98%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $10.14 +0.06 (0.60%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SAVA 10.08 -0.10(-0.98%)
Will SAVA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SAVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SAVA
Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
SAVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross
Other News for SAVA
Trending stocks this week as Trump, IT scares hit markets
Biotech Alert: Searches spiking for these stocks today
First Week of September 20th Options Trading For Cassava Sciences (SAVA)
Largest borrow rate increases among liquid names
H.C. Wainwright Sticks to Their Hold Rating for Cassava Sciences (SAVA)